Sorrento Therapeutics, Inc. (61) | Sales Agreements (4)

Recent Contracts

Amendment No. 1 to Amended and Restated Sales Agreement, dated as of December 23, 2021, by and among Sorrento Therapeutics, Inc., Cantor Fitzgerald & Co., B. Riley Securities,... (Filed With SEC on December 23, 2021)
Amended and Restated Sales Agreement, dated as of December 3, 2021, by and among Sorrento Therapeutics, Inc., Cantor Fitzgerald & Co., B. Riley Securities, Inc., H.C. Wainwright &... (Filed With SEC on December 3, 2021)
Amendment No. 1 to Sales Agreement, dated as of December 4, 2020, by and between Sorrento Therapeutics, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on December 4, 2020)
Sales Agreement, dated as of April 27, 2020, by and between Sorrento Therapeutics, Inc. and A.G.P/Alliance Global Partners (Filed With SEC on April 27, 2020)